<--- Back to Details
First PageDocument Content
Kidney diseases / Kidney / Renal cell carcinoma / Urinary system / Von Hippel–Lindau tumor suppressor / Transitional cell carcinoma / Cancer / Ureteral cancer / Treatment and prognosis of renal cell carcinoma / Medicine / Oncology / Kidney cancer
Date: 2014-12-08 12:24:38
Kidney diseases
Kidney
Renal cell carcinoma
Urinary system
Von Hippel–Lindau tumor suppressor
Transitional cell carcinoma
Cancer
Ureteral cancer
Treatment and prognosis of renal cell carcinoma
Medicine
Oncology
Kidney cancer

maleKidney revised[removed]labels

Add to Reading List

Source URL: www.cancer.gov

Download Document from Source Website

File Size: 954,86 KB

Share Document on Facebook

Similar Documents

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Formal Specication and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document